These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 9450231

  • 1. Molecular pathogenesis of Theiler's murine encephalomyelitis virus-induced demyelinating disease in mice.
    Lipton HL, Jelachich ML.
    Intervirology; 1997; 40(2-3):143-52. PubMed ID: 9450231
    [Abstract] [Full Text] [Related]

  • 2. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice.
    Gerety SJ, Karpus WJ, Cubbon AR, Goswami RG, Rundell MK, Peterson JD, Miller SD.
    J Immunol; 1994 Jan 15; 152(2):908-18. PubMed ID: 7904291
    [Abstract] [Full Text] [Related]

  • 3. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope.
    Gerety SJ, Rundell MK, Dal Canto MC, Miller SD.
    J Immunol; 1994 Jan 15; 152(2):919-29. PubMed ID: 7506740
    [Abstract] [Full Text] [Related]

  • 4. A predominant viral epitope recognized by T cells from the periphery and demyelinating lesions of SJL/J mice infected with Theiler's virus is located within VP1(233-244).
    Yauch RL, Kim BS.
    J Immunol; 1994 Nov 15; 153(10):4508-19. PubMed ID: 7525707
    [Abstract] [Full Text] [Related]

  • 5. Transgenic expression of Theiler's murine encephalomyelitis virus genes in H-2(b) mice inhibits resistance to virus-induced demyelination.
    Lin X, Njenga MK, Johnson AJ, Pavelko KD, David CS, Pease LR, Rodriguez M.
    J Virol; 2002 Aug 15; 76(15):7799-811. PubMed ID: 12097592
    [Abstract] [Full Text] [Related]

  • 6. Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice.
    Njenga MK, Pavelko KD, Baisch J, Lin X, David C, Leibowitz J, Rodriguez M.
    J Virol; 1996 Mar 15; 70(3):1729-37. PubMed ID: 8627694
    [Abstract] [Full Text] [Related]

  • 7. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Lipton HL, Twaddle G, Jelachich ML.
    J Virol; 1995 Apr 15; 69(4):2525-33. PubMed ID: 7884902
    [Abstract] [Full Text] [Related]

  • 8. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. IV. Identification of an immunodominant T cell determinant on the N-terminal end of the VP2 capsid protein in susceptible SJL/J mice.
    Gerety SJ, Clatch RJ, Lipton HL, Goswami RG, Rundell MK, Miller SD.
    J Immunol; 1991 Apr 01; 146(7):2401-8. PubMed ID: 1706400
    [Abstract] [Full Text] [Related]

  • 9. The generation and characterisation of neutralising antibodies against the Theiler's murine encephalomyelitis virus (TMEV) GDVII capsid reveals the potential binding site of the host cell co-receptor, heparan sulfate.
    Upfold N, Ross C, Bishop ÖT, Luke GA, Knox C.
    Virus Res; 2018 Jan 15; 244():153-163. PubMed ID: 29155139
    [Abstract] [Full Text] [Related]

  • 10. Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B.
    Tsunoda I, Wada Y, Libbey JE, Cannon TS, Whitby FG, Fujinami RS.
    J Virol; 2001 Aug 15; 75(16):7494-505. PubMed ID: 11462022
    [Abstract] [Full Text] [Related]

  • 11. Multiple pathways to induction of virus-induced autoimmune demyelination: lessons from Theiler's virus infection.
    Miller SD, Olson JK, Croxford JL.
    J Autoimmun; 2001 May 15; 16(3):219-27. PubMed ID: 11334486
    [Abstract] [Full Text] [Related]

  • 12. A determinant for central nervous system persistence localized in the capsid of Theiler's murine encephalomyelitis virus by using recombinant viruses.
    Adami C, Pritchard AE, Knauf T, Luo M, Lipton HL.
    J Virol; 1998 Feb 15; 72(2):1662-5. PubMed ID: 9445074
    [Abstract] [Full Text] [Related]

  • 13. Theiler's murine encephalomyelitis virus (TMEV): the role of a small out-of-frame protein in viral persistence and demyelination.
    Obuchi M, Ohara Y.
    Jpn J Infect Dis; 1999 Dec 15; 52(6):228-33. PubMed ID: 10738359
    [Abstract] [Full Text] [Related]

  • 14. Astrocytes, not microglia, are the main cells responsible for viral persistence in Theiler's murine encephalomyelitis virus infection leading to demyelination.
    Zheng L, Calenoff MA, Dal Canto MC.
    J Neuroimmunol; 2001 Aug 30; 118(2):256-67. PubMed ID: 11498260
    [Abstract] [Full Text] [Related]

  • 15. The effect of Theiler's murine encephalomyelitis virus (TMEV) VP1 carboxyl region on the virus-induced central nervous system disease.
    Senkowski A, Shim B, Roos RP.
    J Neurovirol; 1995 Mar 30; 1(1):101-10. PubMed ID: 9222346
    [Abstract] [Full Text] [Related]

  • 16. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Cross-specificity among TMEV substrains and related picornaviruses, but not myelin proteins.
    Miller SD, Clatch RJ, Pevear DC, Trotter JL, Lipton HL.
    J Immunol; 1987 Jun 01; 138(11):3776-84. PubMed ID: 2438327
    [Abstract] [Full Text] [Related]

  • 17. Role of sialyloligosaccharide binding in Theiler's virus persistence.
    Zhou L, Lin X, Green TJ, Lipton HL, Luo M.
    J Virol; 1997 Dec 01; 71(12):9701-12. PubMed ID: 9371636
    [Abstract] [Full Text] [Related]

  • 18. Immunization with structural and non-structural proteins of Theiler's murine encephalomyelitis virus alters demyelinating disease.
    Tsunoda I, Libbey JE, Fujinami RS.
    J Neurovirol; 2012 Apr 01; 18(2):127-37. PubMed ID: 22403027
    [Abstract] [Full Text] [Related]

  • 19. Mutation in loop I of VP1 of Theiler's virus delays viral RNA release into cells and enhances antibody-mediated neutralization: a mechanism for the failure of persistence by the mutant virus.
    McCright IJ, Tsunoda I, Libbey JE, Fujinami RS.
    J Neurovirol; 2002 Apr 01; 8(2):100-10. PubMed ID: 11935462
    [Abstract] [Full Text] [Related]

  • 20. Flow cytometric and functional analyses of central nervous system-infiltrating cells in SJL/J mice with Theiler's virus-induced demyelinating disease. Evidence for a CD4+ T cell-mediated pathology.
    Pope JG, Karpus WJ, VanderLugt C, Miller SD.
    J Immunol; 1996 May 15; 156(10):4050-8. PubMed ID: 8621948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.